VWF and neoplasm: The hypercoagulable state that occurs in this context can be attributable to several factors, among those being the malignancy itself (enhanced tissue factor expression by tumor cells), the host's inflammatory response (high levels of tumor cell-derived cytokines, fibrinogen, and von Willebrand factor), and the prothrombotic effects of the treatment [7–9].